Photocure
Bladder cancer medicines, diagnostic tests and imaging technologies for patients and healthcare providers
Highlights
- New on EvolcAdded 2026-10-27
About Photocure
Photocure develops and commercializes medicines, medical devices and diagnostic solutions for bladder cancer. Its products include Hexvix and Cysview for bladder cancer and AssureMDx, a urine-based test supporting early detection and clinical decisions.
The company works with healthcare providers and partners to improve bladder cancer diagnosis and management. Photocure is headquartered in Oslo, Norway, and was founded in 1993.
Product: Commercialized bladder cancer products Hexvix and Cysview, plus AssureMDx, a urine-based diagnostic test.
Jobs at Photocure
No open positions listed right now.
Leadership
- Dan Schneider · President and Chief Executive OfficerSource: company website
- Christopher Thibodeau · Chief Operating Officer BiomarkerSource: company website
- Dennis Camporeale · Chief Financial OfficerSource: company website
- Anja Gossens-von der Heidt · Head of Global Human ResourcesSource: company website
More biotech & pharma companies
Pluvia
Develops small-molecule drugs for patients with rare protein-misfolding disorders, starting with phenylketonuria (PKU)New on EvolcPolypure
Produces uniform polyethylene glycol derivatives for pharmaceutical, biotech, nanotech and research customersNew on EvolcPreviwo
Probiotic products for farmed salmon and trout that strengthen fish health in aquacultureNew on EvolcProphylaxia
Researches salmon signalling substances such as SNAP as a sea lice alternative for salmon farmingNew on EvolcQuantidoc
Immune barrier health monitoring for fish farms and hatcheries using its VERIBARR™ analyses of gills, skin and gutNew on EvolcRegenics
Develops marine-derived wound care products for treating burns and chronic woundsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Next.js
- React
- nginx